New York, NY -- (SBWire) -- 06/18/2019 --The global PEGylated protein therapeutics market was valued at $10,388 million in 2017, and is estimated to reach at $17,813 million by 2025, registering a CAGR of 6.9% from 2018 to 2025. The factors that propel the PEGylated protein therapeutics market growth include high prevalence of chronic diseases, such as cancer, kidney diseases, and rheumatoid arthritis. In addition, growth in the biologics sector with an increase in R&D expenditure of pharmaceutical and biopharmaceutical companies boosts the market. Furthermore, increase in government funding and grants for research activities enhance opportunities for the growth of the market. However, high price, and expected launch of generic drugs can hinder the growth.
Download FREE Sample Brochure @ https://www.marketgrowthinsight.com/sample/38704
PEGylation refers to the process of amalgamation or attachment of polyethylene glycol (PEG) polymer chains with macromolecules, such as drug molecule, therapeutic protein, or vesicles by covalent bonding. PEGylation offers several advantages, such as improved drug solubility, reduced dosage frequency, and increased drug stability, which boost its demand in the market.
KEY PLAYERS PROFILED: Amgen Inc., AstraZeneca PLC, Biogen, Inc., F. Hoffmann-La Roche Ltd. (Genentech, Inc.,), Horizon Pharma plc., Leadiant Biosciences S.p.A., Merck & Co., Inc. (Schering-Plough Corporation), Pfizer Inc., Shire plc (Baxalta), and UCB S.A.
The market intelligence report focuses primarily on the market size, share and growth rate of the industry during the estimated period with the aim to help business owners make a wise investment decision and chalk out a blueprint of profitable business strategies.
Apart from this, the valuable document weighs upon the performance of the industry on the basis of a product service, end-use, geography and end customer.
A high focus is maintained on factors such as demand and supply, production capacity, supply chain management, distribution channel, product application and performance across different countries. The report not only offers hard to find facts about the trends and innovation driving the current and future of PEGylated Protein Therapeutics business, but also provides insights into competitive development such as acquisition and mergers, joint ventures, product launches and technology advancements.
KEY MARKET SEGMENTS
By Product Type
Colony Stimulating Factor
Interferon
Erythropoietin (EPO)
Recombinant Factor VIII
Monoclonal Antibody
Enzyme
Others
By Application Type
Cancer
Autoimmune Disease
Hepatitis
Multiple Sclerosis
Hemophilia
Gastrointestinal Disorder
Others
By Sales Channel
Hospital Pharmacy
Online Provider
Retail Pharmacy
Purchase PEGylated Protein Therapeutics Market Research Report @ https://www.marketgrowthinsight.com/checkout/38704
Region wise performance of the PEGylated Protein Therapeutics industry
This report studies the global PEGylated Protein Therapeutics market status and forecast, categorizes the global PEGylated Protein Therapeutics market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
PEGylated Protein Therapeutics Market Report Highlights:
1.Detailed overview of parent market.
2.Changing market dynamics in the industry.
3.In-depth market segmentation.
4.Historical, current and projected market size in terms of volume and value.
5.Recent industry trends and developments.
6.Competitive landscape.
7.Strategies of key players and products offered.
8.Potential and niche segments, geographical regions exhibiting promising growth.
9.A neutral perspective on market performance.
Report holds answers to important questions:
- What will be the estimated market size and the growth rate of the PEGylated Protein Therapeutics for the forecast period, 2019 - 2025?
- What are the major driving forces shaping the progress of the PEGylated Protein Therapeutics market worldwide?
- Who are the key industry players dominating the PEGylated Protein Therapeutics industry and what has been their performance status so far?
- What are the major trends and challenges that have influenced the growth of the PEGylated Protein Therapeutics market across different regions?
- What type of opportunities can the major market players bank on for the forecast period, 2019 - 2025?
View Full Report @ https://www.marketgrowthinsight.com/38704/pegylated-protein-therapeutics-market
About Market Growth Insight
Market Growth Insight is a one stop solution for market research reports in various business categories. We are serving 100+ clients with 10000+ diverse industry reports and our reports are developed to simplify strategic decision making, on the basis of comprehensive and in-depth significant information, established through wide ranging analysis and latest industry trends.
Contact us :
502, Sai Radhe, Kenedy Road,
Behind Hotel Sheraton Grand,
Near Pune Station, Pune-411001,
Maharashtra, India.
sales@marketgrowthinsight.com
Contact No- + 91 8956 049 020
Website- https://www.marketgrowthinsight.com
PEGylated Protein Therapeutics Market Growth Analysis, Key Manufacturers, Business Overview, Market Insights, Trends and Forecast Period (2018-2025)
The global PEGylated protein therapeutics market was valued at $10,388 million in 2017, and is estimated to reach at $17,813 million by 2025, registering a CAGR of 6.9% from 2018 to 2025.